首页> 外文期刊>Swiss medical weekly: official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology >Dramatic effect of early clopidogrel administration in reducing mortality and MACE rates in ACS patients Data from the Swiss registry AMIS-Plus
【24h】

Dramatic effect of early clopidogrel administration in reducing mortality and MACE rates in ACS patients Data from the Swiss registry AMIS-Plus

机译:早期服用氯吡格雷对降低ACS患者的死亡率和降低MACE率的显著作用瑞士登记处AMIS-Plus的数据

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Patients who have acute coronary syndromes with or without ST-segment elevation have high rates of major vascular events. We evaluated the efficacy of early clopidogrel administration (300 mg) (<24 hours) when given with aspirin in such patients.
机译:背景:患有或不伴ST段抬高的急性冠脉综合征患者的重大血管事件发生率较高。我们评估了阿司匹林在此类患者中早期给予氯吡格雷(300 mg)(<24小时)的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号